Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers August 22, 2017
Pharmacy Choice - News - Drug Delivery Systems - August 22, 2017

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 89     Next >>     Go To Page:

8/22/17 - $889.3 mn for Global Contrast Injector Market by 2022
Zion Market Research has published a new report titled "Contrast Injector Market by Product (Injector Systems, Consumables, Accessories), & Application (Radiology, Interventional Cardiology, Interventional Radiology) - Global Indust...
8/22/17 - ALK to accelerate launches of ODACTRA in the USA / ACARIZAX in Canada [T-break Tech (Middle East)]
The FDA has today transferred the US product licences for the SLIT-tablet portfolio to ALK allowing the company to give full speed on the US activities. ALK plans to expand pivotal Phase III clinical trial on allergic asthma to include US patients based on discussions with the FDA. Full-year financial guidance for operating profit has been revised
8/22/17 - Alkermes Initiates Rolling Submission of ALKS 5461 New Drug Application for Major Depressive Disorder
Release date- 21082017- DUBLIN- Alkermes plc today announced the initiation of its rolling submission of a New Drug Application to the U.S. Food and Drug Administration, seeking marketing approval of ALKS 5461, a once daily, oral investigational medicine with a novel mechanism of action, for the adjunctive treatment of major depressive disorder.
8/22/17 - Analysis on Implantable Drug Delivery Devices Market Report Upto 2023
The new research report on Implantable Drug Delivery Devices Market offered by DecisionDatabases.com provides Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016-2023. The global implantable drug delivery devices market research r...
8/22/17 - Aurobindo Pharma gets USFDA nod for anti-HIV drug [Arab News (Saudi Arabia)]
Aurobindo Pharma has received tentative approval from the USFDA for dolutegravir, lamivudine and tenofovir disoproxil fumarate tablets, used for the treatment of HIV, in the US market. In a BSE filing, Aurobindo Pharma said it has received "tentative approval from the US Food and Drug Administration under the US President`s Emergency Plan For AIDS
8/22/17 - BCC to Enter Into Joint Venture With Israeli Pharmaceutical Company Panaxia
The Canadian Bioceutical Corporation today announced the signing of a Term Sheet outlining the binding conditions under which it will enter into a Joint Venture agreement with Panaxia Pharmaceutical Industries Ltd.. Under the terms of the agreement, Panaxia will be providing proprietary, smokeless, pharma-grade cannabis-based products that have b
8/22/17 - CURE Pharmaceutical Subsidiary, Oak Therapeutics, Completes Critical Milestone in Phase 1 of NIH Grant to Develop Oral Dissolvable Strip for Tuberculosis
CURE Pharmaceutical,, a leading disruptive drug delivery technology company, today announced that its subsidiary company, Oak Therapeutics, has completed a critical milestone of its Phase I Small Business Innovative Research Contract from the National Institutes of Health/National Institute of Allergy and Infectious Diseases to develop a formulat
8/22/17 - Ironwood Pharmaceuticals Announces FDA Approval of DUZALLO for the Treatment of Hyperuricemia in Patients with Uncontrolled Gout
Release date- 21082017- CAMBRIDGE, Mass.- Ironwood Pharmaceuticals, Inc. today announced DUZALLO was approved by the U.S. Food and Drug Administration as a once daily oral treatment for hyperuricemia associated with gout in patients who have not achieved target serum uric acid levels with a medically appropriate daily dose of allopurinol alone.
8/22/17 - Lee's Pharmaceutical Holdings Limited - Zingo for Needle free Local Analgesia is approved by Hong Kong Department of Health
Release date- 21082017- Lee's Pharmaceutical Holdings Limited, an integrated research driven and market oriented pharmaceutical group in China is pleased to announce that Powder Pharmaceuticals, Incorporated, an associated company of the Group, has obtained product registration certificate of Zingo from Hong Kong Department of Health.
8/22/17 - Maricann Group Inc. Announces Acquisition of NanoLeaf Technologies Inc., Appoints New President and Chief Operating Officer
Maricann Group Inc. announced today that it has entered into an agreement to acquire 100% of the issued and outstanding shares of NanoLeaf Technologies Inc., a biotech company possessing licensing rights to a number of globally patented technologies that provide proven pharmaceutical, nutraceutical, cosmetic and functional beverage drug delivery...
8/22/17 - Perrigo Announces Final FDA Approval and Settlement for the Store Brand OTC Equivalent of Nexium 24HR Capsules
Release date- 21082017- DUBLIN- Perrigo Company plc today announced that it has received final approval from the U.S. Food& Drug Administration for the store brand OTC equivalent of Nexium 24 HR capsules. The company also announced that it has reached a settlement of patent litigation with AstraZeneca allowing for the store brand OTC equivalent of
8/22/17 - Pfizers Besponsa gets FDA approval for treatment of B-cell precursor ALL [Algeria Press Service]
Developed jointly by Pfizer and Celltech, now known as UCB, Besponsa is an antibody-drug conjugate made up of a monoclonal antibody targeting CD22, a cell-surface antigen expressed on cancer cells in almost all B-ALL patients linked to a cytotoxic agent. Pfizer oncology global president Liz Barrett said: The approval of Besponsa is an important ste
8/22/17 - Teikoku Pharma USA Announces Positive Topline Results from Phase 2 Clinical Trial of TPU-006, NonOpioid Pain Management Patch in Bunionectomy Surgery
Teikoku Pharma USA, Inc. today announced positive topline results from its Phase 2 proof of concept study of TPU-006, a 3- day dexmedetomidine transdermal patch, a novel drug delivery system with a non-opioid active moiety for the management of post-surgical pain. The preliminary results demonstrate that the patch provides effective pain control
8/22/17 - Transdermal Skin Patches Market - Global Industry Volume and Region Analysis 2025
Albany, NY 08/22/2017 Kingdom of Saudi Arabia Transdermal Skin Patches Market: SnapshotTraditional drug delivery methods like capsules, pills, liquids, intravenous needles and powders are often ineffective and may result in undesirable side effects. Transdermal delivery constitutes an important and effective route for new drug delivery.
8/21/17 - Acella Pharmaceuticals Signs Product Development Agreement with Catalent To Bring Opioid-Abuse Deterrents to Market
By a News Reporter-Staff News Editor at Pharma Business Week Acella Pharmaceuticals, LLC, a leading U.S. manufacturer of specialty pharmaceuticals across several therapeutic categories, announced an exclusive, multi-year, multi-product development and licensing partnership with Catalent Pharma Solutions, the leading global provider of advanced...
8/21/17 - ALK to accelerate launches of ODACTRA? in the USA / ACARIZAX in Canada
The FDA has today transferred the US product licences for the SLIT-tablet portfolio to ALK allowing the company to give full speed on the US activities ALK will bring forward the North American launches of the house dust mite SLIT-tablet from mid-2018 to Q4 2017 ALK plans to expand pivotal Phase III clinical trial on allergic asthma to include US p
8/21/17 - Alkermes Initiates Rolling Submission of ALKS 5461 New Drug Application for Major Depressive Disorder
Alkermes plc today announced the initiation of its rolling submission of a New Drug Application to the U.S. Food and Drug Administration, seeking marketing approval of ALKS 5461, a once-daily, oral investigational medicine with a novel mechanism of action, for the adjunctive treatment of major depressive disorder. At a pre-NDA interaction with FDA
8/21/17 - Aurobindo Pharma receives USFDA tentative approval for Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate tablets
Release date- 21082017- Aurobindo Pharma Limited is pleased to announce that the company has received tentative approval from the U.S. Food& Drug Administration under the U.S. President's Emergency Plan for AIDS Relief for its New Drug Application for Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate tablets, 50 mg/300mg/300mg.
8/21/17 - Bharat Book Bureau: Global Drug Delivery Market - Trends and Forecast to 2022
The global drug delivery devices market is segmented into 5 regions such as North America, Europe, Asia-Pacific, South America and Middle East and Africa. These regions are further classified on the basis of country, into major countries such as U.S., Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singap
8/21/17 - Bharat Book Bureau: Global Topical Drug Delivery Market - Trends and Forecast to 2024
Global Topical Drug Delivery Market is expected to reach USD 194.2 billion by 2024, at a CAGR 9.3% during the forecast period of 2017 to 2024. The report contains 300 pages of exclusive premium insights with 290 tables and 25 figures. Topical drug delivery involves the introduction of a medication to the body surface such as skin or mucous membrane
8/21/17 - Bharat Book Bureau: North America Drug Delivery Market - Trends and Forecast to 2024
North America Drug Delivery Market is expected to reach USD 823.55 billion by 2024, at a CAGR of 6.4% during the forecast period of 2017 to 2024. The North America drug delivery market is segmented into 3 major countries such as U.S., Canada, and Mexico. Johnson& Johnson Services, Inc., Novartis AG, F. Hoffmann-La Roche AG, Pfizer, Inc., GlaxoSmith
8/21/17 - Bharat Book Bureau: North America Injectable Drug Delivery Market - Industry Trends and Forecast to 2024
North America injectable drug delivery market is expected to reach USD 354.5 billion by 2024 from USD 154.0 billion in 2016, at a CAGR of 11.0% in the forecast period 2017 to 2024. North America injectable drug delivery market is segmented on the basis of type, applications, usage pattern, mode of administration, end user, and country. Baxter Inter
8/21/17 - Cycle Pharmaceuticals Partners with Cardinal as the Logistic Provider for NityrTM in U.S.
By a News Reporter-Staff News Editor at Pharma Business Week Cycle Pharmaceuticals has selected Cardinal Health Inc. as the importer and distributor of its nitisinone tablets Nityr? to Diplomat Pharmacy, Inc. Cycle and Cardinal have entered an agreement where Cardinal is the exclusive U.S. logistic provider. "Cardinal Health is a leading whole
8/21/17 - Findings from Chongqing University Update Knowledge of Drug Delivery Systems (Non-invasive approaches for drug delivery to the brain based on the...
By a News Reporter-Staff News Editor at Journal of Engineering Research findings on Drugs and Therapies- Drug Delivery Systems are discussed in a new report. According to news reporting originating in Chongqing, People's Republic of China, by VerticalNews journalists, research stated, "The blood brain barrier is a physical and biochemical barrier
8/21/17 - Global Contrast Injector Market Will Reach USD 889.3 Million by 2022: Zion Market Research
Zion Market Research has published a new report titled Contrast Injector Market by Product,& Application- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2016 2022. The global contrast injector market was valued at around USD 660.0 million in 2016 and is expected to reach approximately USD 889.3 million by 2022, growin
Articles(s): 1 - 25 of 89     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415